INOGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 54.43K shares, a 1455.64% increase year-over-year.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 54.43K shares, a 284.57% increase from fiscal 2022.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 14.15K shares, a 97.09% decline from fiscal 2021.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 486.04K shares, a 2509.46% increase from fiscal 2020.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 18.63K shares, a 82.96% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 54.43K shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 59.94K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 59.94K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 54.43K shares 10-Q · filed 2023-05-05 | 65.09K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 5.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 14.15K shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 8.65K shares derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | 5.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 117.39K shares derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | 3.50K shares 10-Q · filed 2022-05-05 | 283.78K shares derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 486.04K shares 10-K · filed 2024-03-01 |
| 2021-09-30 | 108.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 495.34K shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | 171.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 386.60K shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | 205.75K shares 10-Q · filed 2021-05-04 | 218.04K shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | 9.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | 18.63K shares 10-K · filed 2023-02-24 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 36.56K shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | 2.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 43.30K shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | 6.33K shares 10-Q · filed 2020-05-05 | 45.85K shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | 27.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 109.29K shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 6.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 355.65K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | 5.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 507.62K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | 69.78K shares 10-Q · filed 2019-05-07 | 608.50K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | 273.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 708.32K shares 10-K · filed 2021-02-24 |
| 2018-09-30 | 158.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 559.38K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 106.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 488.28K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 169.59K shares 10-Q · filed 2018-04-30 | 532.58K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 124.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 520.39K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 87.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 541.36K shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | 150.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 609.38K shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | 157.41K shares 10-Q · filed 2017-05-09 | 650.13K shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | 145.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 570.08K shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 155.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 604.97K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | 191.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 677.32K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | 77.36K shares 10-Q · filed 2016-05-09 | 549.74K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | 180.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 676.72K shares 10-K · filed 2018-02-27 |
| 2015-09-30 | 227.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 988.89K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | 63.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 911.33K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | 204.33K shares 10-Q · filed 2015-05-12 | 931.88K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | 492.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 736.52K shares 10-K · filed 2017-02-28 |
| 2014-09-30 | 150.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | |
| 2014-06-30 | 84.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | |
| 2014-03-31 | 8.97K shares 10-Q · filed 2014-05-13 | |
| 2013-12-31 | 8.87K shares 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |